138 related articles for article (PubMed ID: 16374120)
1. F-18 FDG PET superscan.
Su HY; Liu RS; Liao SQ; Wang SJ
Clin Nucl Med; 2006 Jan; 31(1):28-9. PubMed ID: 16374120
[No Abstract] [Full Text] [Related]
2. FDG-PET in a case of multiple bone metastases of gastric cancer.
Nakai T; Okuyama C; Kubota T; Ushijima Y; Nishimura T
Ann Nucl Med; 2005 Feb; 19(1):51-4. PubMed ID: 15770974
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT superscan in prostate cancer.
Bailly M; Besse H; Kerdraon R; Metrard G; Gauvain S
Clin Nucl Med; 2014 Oct; 39(10):912-4. PubMed ID: 24566401
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
5. Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT.
Kim J; Quon A; Humke E; Ford JM; Koong AC
Clin Nucl Med; 2009 May; 34(5):312-3. PubMed ID: 19387214
[No Abstract] [Full Text] [Related]
6. Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
Picchio M; Landoni C; Messa C; Gianolli L; Matarrese M; De Cobelli F; Maschio AD; Fazio F
AJR Am J Roentgenol; 2002 Aug; 179(2):482-4. PubMed ID: 12130458
[No Abstract] [Full Text] [Related]
7. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
Kim MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2008 Feb; 44(2):148-52. PubMed ID: 17350879
[TBL] [Abstract][Full Text] [Related]
8. False-positive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases.
Ida S; Watanabe M; Yamao T; Ishimoto T; Nagai Y; Iwatsuki M; Baba Y; Iwagami S; Sakamoto Y; Miyamoto Y; Baba H
Surg Today; 2014 Nov; 44(11):2191-4. PubMed ID: 24906431
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
Zhang L; Chen L; Xie Q; Zhang Y; Cheng L; Li H; Wang J
BMC Med Imaging; 2015 Mar; 15():7. PubMed ID: 25885599
[TBL] [Abstract][Full Text] [Related]
11. False-positive FDG-PET scan due to brown tumours.
van Baardwijk A; de Jong J; Arens A; Thimister P; Verseput G; Kremer B; Lambin P
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):393-4. PubMed ID: 16385408
[No Abstract] [Full Text] [Related]
12. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
[TBL] [Abstract][Full Text] [Related]
13. [State of the art in nuclear imaging for the diagnosis of bone metastases].
Ouvrier MJ; Vignot S; Thariat J
Bull Cancer; 2013 Nov; 100(11):1115-24. PubMed ID: 24153039
[TBL] [Abstract][Full Text] [Related]
14. Avoidance of misinterpretation of an FDG positive sacral insufficiency fracture using PET/CT scans in a patient with endometrial cancer: a case report.
Halaç M; Mut SS; Sönmezoglu K; Ylmaz MH; Ozer H; Uslu I
Clin Nucl Med; 2007 Oct; 32(10):779-81. PubMed ID: 17885357
[TBL] [Abstract][Full Text] [Related]
15. Fluorodeoxyglucose positron emission tomography scan of prostate cancer bone metastases with flare reaction after endocrine therapy.
Shimizu N; Masuda H; Yamanaka H; Oriuchi N; Inoue T; Endo K
J Urol; 1999 Feb; 161(2):608-9. PubMed ID: 9915462
[No Abstract] [Full Text] [Related]
16. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
[TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG PET/CT scans for children and adolescents.
Lassmann M; Eberlein U; Tosi G; Chiti A
Lancet Oncol; 2014 Jun; 15(7):e243-4. PubMed ID: 24872098
[No Abstract] [Full Text] [Related]
18. Clinical impact of (18)F-FDG PET in management of patients with renal cell carcinoma.
Rodríguez Martínez de Llano S; Jiménez-Vicioso A; Mahmood S; Carreras-Delgado JL
Rev Esp Med Nucl; 2010; 29(1):12-9. PubMed ID: 20022140
[TBL] [Abstract][Full Text] [Related]
19. False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases.
An YS; Yoon JK; Lee MH; Joh CW; Yoon SN
Clin Nucl Med; 2005 Mar; 30(3):203-4. PubMed ID: 15722832
[No Abstract] [Full Text] [Related]
20. (18)F-FDG PET/CT scans for children and adolescents - authors' reply.
Daldrup-Link H; Quon A; Goske M
Lancet Oncol; 2014 Jun; 15(7):e244. PubMed ID: 24872100
[No Abstract] [Full Text] [Related]
[Next] [New Search]